An estimated 1.6 million children and teenagers would be eligible for the medication, to be sold as Palforzia, an intended for ages 4 to 17.
Read More
Read More
Friday, September 13, 2019
Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment